Possible association between tumor-suppressor gene mutations and hMSH2/hMLH1 inactivation in alveolar soft part sarcoma

Human Pathology

Volumn 34, Issue 9, 2003, Pages 841-849

  Saito, Tsuyoshi ^b   Oda, Yoshinao ^b   Kawaguchi, Ken Ichi ^b   Takahira, Tomonari ^b   Yamamoto, Hidetaka ^b   Sakamoto, Akio ^b   Tamiya, Sadafumi ^b   Iwamoto, Yukihide ^b   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

Alveolar soft part sarcoma; DNA mismatch repair gene; Loss of heterozygosity; Methylation specific polymerase chain reaction, microsatellite instability; Mutation; Prognosis; Tumor suppressor gene

Indexed keywords

PROTEIN MLH1;

ADOLESCENT; ADULT; AGED; ALVEOLAR SOFT PART SARCOMA; ARTICLE; BETA CATENIN GENE; CANCER GRADING; CHILD; CHROMOSOME 5Q; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MISMATCH REPAIR GENE; E CADHERIN GENE; EXON; FEMALE; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HMLH1 GENE; HMSH2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MISMATCH REPAIR; MISSENSE MUTATION; MUTAGENESIS; MUTATIONAL ANALYSIS; ONCOGENE; PATHOGENESIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

EID: 0141651994     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(03)00343-5     Document Type: Article

References (45)

1. Enzinger FM, Weiss SW: Malignant soft tissue tumors of uncertain type, in Enzinger FM, Weiss SW (eds): Soft Tissue Tumors (ed 4). St. Louis, MO, Mosby, 2001, pp 1509-1521
2. Portera CA Jr, Ho V, Patel SR, et al: Alveolar soft part sarcoma. Clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer 91:585-591, 2001
3. Lieberman PH, Brennan MF, Kimmel M, et al: Alveolar soft-part sarcoma. A clinicopathologic study of half a century. Cancer 63:1-13, 1989
4. Ladanyi M, Lui MY, Antonescu CR, et al: The der(17)t(X; 17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 20:48-57, 2001
5. Joyama S, Ueda T, Shimizu K, et al: Chromosome rearrangement at 17q25 and Xp11.2 in alveolar soft-part sarcoma. Cancer 86:1246-1250, 1999
6. Auerbach HE, Brooks JJ: Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study. Cancer 60:66-73, 1987
7. Miettinen M, Ekfors T: Alveolar soft part sarcoma. Immunohistochemical evidence for muscle cell differentiation. Am J Clin Pathol 93:32-38, 1990
8. Kiuru-Kuhlefelt S, El-Rifai W, Sarlomo-Rikala M, et al: DNA copy number changes in alveolar soft part sarcoma: A comparative genomic hybridization study. Mod Pathol 11:227-231, 1998
9. Sanjuan X, Sobel ME, Yang J, et al: Alveolar soft part sarcoma: The role of prognostic markers. Ann Diagn Pathol 4:135-142, 2000
10. Fishel R, Lescoe MK, Rao MR, et al: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038, 1994
11. Leach FS, Nicolaides NC, Papadopoulos N, et al: Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer. Cell 75:1215-1225, 1993
12. Kang GH, Shim YH, Ro JY: Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinomas with replication error. Lab Invest 79:903-909, 1999
13. Fleisher A, Esteller M, Wang S, et al: Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 59:1090-1095, 1999
14. Leung S, Yuen S, Chung L, et al: hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 59:159-164, 1999
15. Simpkins S, Bocker T, Swisher E, et al: MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet 8:661-666, 1999
16. Herman JG, Umar A, Polyak K, et al: Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 95:6870-6875, 1998
17. Dietmaier W, Wallinger S, Bocker T, et al: Diagnostic microsatellite instability: Definition and correlation with mismatch repair expression. Cancer Res 57:4749-4756, 1997
18. Thibodeau SN, French AJ, Cunningham JM, et al: Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58:1713-1718, 1998
19. Thibodeau SN, French AJ, Roche PC, et al: Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56: 4836-4840, 1996
20. Fleming ID, Cooper JS, Henson DE, et al (eds): American Joint Committee on Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott Raven, 1997, pp 149-156
21. Saito T, Oda Y, Sakamoto A, et al: Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of β-catenin mutation in synovial sarcoma. J Pathol 192:342-350, 2000
22. Oda Y, Sakamoto A, Saito T, et al: Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma. HUM PATHOL 31:185-192, 2000
23. Berx G, Cleton-Jansen A-M, Nollet F, et al: E-cadherin is a tumour/invasion-suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107-6115, 1995
24. Saito A, Kanai Y, Maesawa C, et al: Disruption of E-cadherin-mediated cell adhesion systems in gastric cancers in young patients. Jpn J Cancer Res 90:993-999, 1999
25. Oda Y, Sakamoto A, Saito T, et al: Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Mod Pathol 13:994-1004, 2000
26. Yagi OK, Akiyama Y, Ohkura Y, et al: Analyses of the APC and TGF-β type II receptor genes, and microsatellite instability in mucosal colorectal carcinoma. Jpn J Cancer Res 88:718-724, 1997
27. Iwao K, Nakamori S, Kameyama M, et al: Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58:1021-1026, 1998
28. Herman JG, Graff JR, Myohanen S, et al: Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93:9821-9826, 1996
29. Oda S, Oki E, Maehara Y, et al: Precise assessment of microsatellite instability using high-resolution fluorescent microsatellite analysis. Nucleic Acids Res 25:3415-3420, 1997
30. Boland CR, Thibodeau SN, Hamilton SR, et al: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257, 1998
31. Toguchida J, Yamaguchi T, Ritchie B, et al: Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52:6194-6199, 1992
32. Saito T, Oda Y, Sugimachi K, et al: E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features. Am J Pathol 159:2117-2124, 2001
33. Saito T, Oda Y, Sakamoto A, et al: APC mutations in synovial sarcoma. J Pathol 196:445-449, 2002
34. Schneider-Stock R, Onnasch D, Haeckel C, et al: Prognostic significance of p53 gene mutations and p53 protein expression in synovial sarcomas. Virchows Arch 435:407-412, 1999
35. Konomoto T, Fukuda T, Hayashi K, et al: Leiomyosarcoma in soft tissue: Examination of p53 status and cell proliferating factors in different locations. HUM PATHOL 29:74-81, 1998
36. Mastrangelo D, Hadjistilianou T, Mazzotta C, et al: Microsatellite instability in three cases of embryonal rhabdomyosarcoma of the orbit. Med Pediatr Oncol 39:132-133, 2002
37. Aue G, Hedges LK, Schwartz HS, et al: Clear cell sarcoma or malignant melanoma of soft parts: Molecular analysis of microsatellite instability with clinical correlation. Cancer Genet Cytogenet 105: 24-28, 1998
38. Martin SS, Hurt WG, Hedges LK, et al: Microsatellite instability in sarcomas. Ann Surg Oncol 5:356-360, 1988
39. Kuhnen C, Herter P, Monse H, et al: APC and beta-catenin in alveolar soft part sarcoma (ASPS): Immunohistochemical and molecular genetic analysis. Pathol Res Pract 196:299-304, 2000
40. Guilford P, Hopkins J, Harraway J, et al: E-cadherin germline mutations in familial gastric cancer. Nature 392:402-405, 1998
41. Oda T, Kanai Y, Oyama T, et al: E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci U S A 91: 1858-1862, 1994
42. Endo K, Ashida K, Miyake N, et al: E-cadherin gene mutations in human intrahepatic cholangiocarcinoma. J Pathol 193:310-317, 2001
43. Soares P, Berx G, van Roy F, et al: E-cadherin gene alterations are rare events in thyroid tumors. Int J Cancer 70:32-38, 1997
44. Ladanyi M: Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene 20:5755-5762, 2001
45. dos Santos NR, de Bruijn DR, Geurts van Kessel A: Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 30:1-14, 2001